Barriers to optimizing inflammatory bowel disease care in the United States

Significant progress in the management and modification of inflammatory bowel disease (IBD) has been made; however, significant barriers to the optimization of IBD care in the United States still exist. The majority of these barriers are constructed by insurance carriers and the integration of marke...

Descripción completa

Detalles Bibliográficos
Autores principales: Spencer, Elizabeth A., Abbasi, Sadeea, Kayal, Maia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
IBD Barriers Across the Continents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164253/
https://www.ncbi.nlm.nih.gov/pubmed/37163167
http://dx.doi.org/10.1177/17562848231169652
Descripción
Sumario:Significant progress in the management and modification of inflammatory bowel disease (IBD) has been made; however, significant barriers to the optimization of IBD care in the United States still exist. The majority of these barriers are constructed by insurance carriers and the integration of market pressures into healthcare decision-making. In this review, we highlight the barriers to IBD care optimization within the context of the US insurance system and review current and proposed solutions.

Ejemplares similares